377 Glucocorticoid receptor-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 292 | 142.8 | 2.04× | q < 0.0001 | |
| Mixed metal/non-metal compounds | 5 | 6.1 | 0.82× | q = 0.89 | |
| Organosulfur compounds | 2 | 6.0 | 0.33× | q = 0.20 | |
| Nucleosides, nucleotides, and analogues | 13 | 80.4 | 0.16× | q < 0.0001 | |
| Organoheterocyclic compounds | 5 | 44.8 | 0.11× | q < 0.0001 | |
| Organic nitrogen compounds | 1 | 9.3 | 0.11× | q = 4.6e-3 | |
| Lipids and lipid-like molecules | 3 | 32.4 | 0.09× | q < 0.0001 | |
| Homogeneous non-metal compounds | 4 | 62.6 | 0.06× | q < 0.0001 | |
| Organic oxygen compounds | 3 | 57.9 | 0.05× | q < 0.0001 | |
| Benzenoids | 1 | 21.3 | 0.05× | q < 0.0001 | |
| Organic acids and derivatives | 2 | 45.0 | 0.04× | q < 0.0001 | |
| Phenylpropanoids and polyketides | 0 | 6.1 | 0 | q = 0.01 |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02452 | TTP | Thymidine 5'-triphosphate | 40 |
| DB04485 | THM | Thymidine | 13 |
| DB02746 | — | Phthalic Acid | 7 |
| DB00210 | — | — | 6 |
| DB00459 | — | — | 6 |
| DB00926 | — | — | 6 |
| DB00132 | — | alpha-Linolenic acid | 5 |
| DB00197 | — | — | 5 |
| DB00412 | — | Rosiglitazone | 5 |
| DB01393 | — | Bezafibrate | 5 |
| DB00799 | — | — | 4 |
| DB01395 | — | — | 4 |
| DB03566 | SPD | Spermidine | 4 |
| DB04224 | — | Oleic Acid | 4 |
| DB11638 | — | — | 4 |
| DB14128 | NAD | Nadide | 4 |
| DB00313 | — | — | 3 |
| DB00588 | — | — | 3 |
| DB00675 | — | Tamoxifen | 3 |
| DB01708 | — | Prasterone | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 3,138 |
| MGmetal | MAGNESIUM ION | 1,549 |
| OHX | osmium (III) hexammine | 197 |
| Kmetal | POTASSIUM ION | 116 |
| CDmetal | CADMIUM ION | 66 |
| TTP | THYMIDINE-5'-TRIPHOSPHATE | 41 |
| UNX | UNKNOWN ATOM OR ION | 35 |
| CL | CHLORIDE ION | 16 |
| SPD | SPERMIDINE | 16 |
| MNmetal | MANGANESE (II) ION | 14 |
| THM | THYMIDINE | 13 |
| NAmetal | SODIUM ION | 9 |
| QBT | [(2R,3S,5R)-3-HYDROXY-5-[(5S)-5-METHYL-2,4-DIOXO-1,3-DIAZINAN-1-YL]OXOLAN-2-YL]METHYL DIHYDROGEN PHOSPHATE | 9 |
| 1N7 | CHAPSO | 7 |
| IOD | IODIDE ION | 5 |
| 4TA | P1-(5'-ADENOSYL)P4-(5'-(2'-DEOXY-THYMIDYL))TETRAPHOSPHATE | 4 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 4 |
| PAR | PAROMOMYCIN | 4 |
| SJT | spliceostatin A (form II) | 4 |
| 2ON | 2-sulfanyl-1,9-dihydro-6H-purin-6-one | 3 |